Parse Biosciences
Seattle, United States· Est.
The Parse Evercode™ single-cell technology enables all scales of experiments without the limitations of today's microfluidics approaches.
Private Company
Total funding raised: $76M
About
The Parse Evercode™ single-cell technology enables all scales of experiments without the limitations of today's microfluidics approaches.
Genetics & Genomics
Funding History
3Total raised:$76M
Series B$50M
Series A$23.5M
Seed$2.5M